Pharma Foods International Co., Ltd.

Tokyo Stock Exchange 2929.T

Pharma Foods International Co., Ltd. Total Non-Current Liabilities for the year ending July 31, 2024: USD 12.17 M

Pharma Foods International Co., Ltd. Total Non-Current Liabilities is USD 12.17 M for the year ending July 31, 2024, a -22.25% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

Pharma Foods International Co., Ltd. Total Non-Current Liabilities for the year ending July 31, 2023 was USD 15.66 M, a 61.48% change year over year.
Pharma Foods International Co., Ltd. Total Non-Current Liabilities for the year ending July 31, 2022 was USD 9.70 M, a -29.23% change year over year.
Pharma Foods International Co., Ltd. Total Non-Current Liabilities for the year ending July 31, 2021 was USD 13.70 M, a -38.26% change year over year.
Pharma Foods International Co., Ltd. Total Non-Current Liabilities for the year ending July 31, 2020 was USD 22.19 M, a 16.20% change year over year.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

Tokyo Stock Exchange: 2929.T

Pharma Foods International Co., Ltd.

CEO	Mr. Mu Jo Kim
IPO Date	June 12, 2006
Location	Japan
Headquarters	1-49 Goryo-Ohara
Employees	642
Sector	Healthcare
Industries Biotechnology Cosmetics Non-Alcoholic Beverages Personal Care Pet Food Pharmaceuticals Plastics Snack Foods

Description

Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. Its products include Pharma-GABA, Bonepep, Ovopron (egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid. Pharma Foods International Co., Ltd. has licensing agreement with Mitsubishi Tanabe Pharma Corporation for a new therapeutic antibody to treat autoimmune diseases. Pharma Foods International Co., Ltd. was founded in 1997 and is based in Kyoto, Japan.

Key trends

Past 5 years